Topical nitroglycerin: Phase I/II; marketed as Cellogesic in Australia

In a 4-6 week open-label U.S. Phase I/II study in 34 female patients with vulvodynia, NTG applied before sex improved pain in 91.5% (31/34) of patients. Pain intensity decreased (p<0.0001) as did freq...